2018 (4th) International Symposium on Next-Generation CAR & TCR-T Cells
Chimeric antigen receptors ARe engineered receptors that combine a new specificity with an immune cell to tARget cancer cells. Typically, these receptors graft the specificity of a monoclonal antibody onto a T cell. CAR-T cells ARe a new type of treatment that uses living cells that have been transformed.
2018 International Forum on RARe Diseases and Orphan Drugs
In some pARts of the world, an orphan disease is a rARe disease whose rARity means there is a lack of a mARket lARge enough to gain support and resources for discovering treatments for it, except by the government granting economically advantageous conditions to creating and selling such treatments. Orphan drugs ARe ones so created or sold.
2018 International Symposium on Neonatal HereditARy Diseases and Translational Medicine
Monogenic diseases ARe frequent causes of neonatal morbidity and mortality, and disease presentations ARe often undifferentiated at birth. More than 3500 monogenic diseases have been chARacterized, but clinical testing is available for only some of them and many feature clinical and genetic heterogeneity.
Shanghai Symposium of DNA Encoded LibrARy technology and application
The appeARance and application of DNA-encoded chemical librARies (DEL) ARe gradually changing the vision of small molecule drug R&D. The " Shanghai Symposium of DNA Encoded LibrARy technology and application" will be organized and hosted by Bioon and Shanghai Institute of Materia Medica, Chinese Academy of Sciences in Shanghai on June 29, 2018.
下一代CAR与免疫细胞治疗研讨会
过去一年来，细胞免疫治疗成为行业内最大的热点话题，而CAR-T"治愈"血液瘤及在临床上的突破进展正是此轮细胞治疗大热的引爆点，在2015年美国临床肿瘤学会年会上，CAR-T治疗又有新进展：胰腺癌，iCaspase安全开关。 本次会议主题从CAR-T发展现状与趋势、下一代CAR-T技术热点 、CAR-T临床研究情况三个专题，采用主题演讲、学术交流的形式